Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Pharmacologic Pain Management

Phase 3Small molecule

UUniversity of California, San Francisco

2

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Postsurgical Pain ManagementNot yet recruiting

Postsurgical Pain ManagementPhase 3

Not yet recruiting

Timeline

Expected Milestones

Q3 2028

Phase 3Not yet recruiting

Postsurgical Pain Management

NCT07296770

Clinical

Trials by Indication[1]

Postsurgical Pain Management1 trial

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

Not yet recruiting·UUniversity of California, San Francisco·Phase 3·NCT07296770·126 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Pharmacologic Pain Management. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pharmacologic Pain Management compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pharmacologic Pain Management. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, San Francisco company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity of California, San Francisco

Related News